358.05
-13.60
(-3.66%)
At close: January 10 at 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
2,526,160.00
1,867,160.00
3,153,090.00
2,937,330.00
2,290,180.00
Investing Cash Flow
-1,400,450.00
-1,737,450.00
-2,923,400.00
-2,843,710.00
-1,561,960.00
Financing Cash Flow
-1,033,980.00
-269,980.00
-76,800.00
-55,580.00
-968,680.00
End Cash Position
201,730.00
127,030.00
267,300.00
114,000.00
76,360.00
Capital Expenditure
-1,471,960.00
-2,041,960.00
-3,026,200.00
-2,733,140.00
-1,575,990.00
Issuance of Debt
1,100,000.00
350,000.00
2,900,000.00
1,350,000.00
600,000.00
Repayment of Debt
-868,230.00
-837,230.00
-1,212,270.00
-887,130.00
-872,600.00
Free Cash Flow
1,054,200.00
-174,800.00
126,890.00
204,190.00
714,190.00
3/31/2021 - 7/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FDC.NS FDC Limited
488.55
-0.06%
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
GUFICBIO.NS Gufic Biosciences Limited
468.40
+1.68%
STAR.NS Strides Pharma Science Limited
647.15
-1.78%
PARNAXLAB.BO Parnax Lab Limited
164.05
+6.73%
NOVARTIND.BO Novartis India Limited
879.60
-3.76%
STAR.BO Strides Pharma Science Limited
647.35
-1.74%
HESTERBIO.NS Hester Biosciences Limited
2,264.20
-3.48%